Telemus Capital »

Regeneron Pharmaceuticals shares owned by Telemus Capital

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Telemus Capital from 13F filings

Historical chart of Telemus Capital investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Telemus Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Telemus Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $703k 800 878.29
2023-09-30 $658k 799 822.96
2023-06-30 $576k 802 718.54
2023-03-31 $477k 581 821.67
2022-12-31 $444k 602 737.15
2022-09-30 $395k 573 689.35
2022-06-30 $339k 573 591.62
2022-03-31 $259k 371 698.11
2021-12-31 $231k 365 632.88
2021-09-30 $222k 367 604.90
2021-06-30 $882k 1.6k 558.23
2021-03-31 $693k 1.4k 484.62
2020-12-31 $415k 860 482.56
2020-09-30 $940k 1.6k 599.87
2020-06-30 $355k 572 620.63
2020-03-31 $351k 572 613.64
2017-12-31 $15k 40 375.00
2017-09-30 $1.8M 4.0k 447.08
2017-06-30 $2.0M 4.0k 491.10